Molecular-Targeted Therapies for Hematologic Malignancies

Saved in:
Bibliographic Details
Main Authors: Kevin D. Bunting, Cheng-Kui Qu, Michael H. Tomasson
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Advances in Hematology
Online Access:http://dx.doi.org/10.1155/2012/606423
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849401766528942080
author Kevin D. Bunting
Cheng-Kui Qu
Michael H. Tomasson
author_facet Kevin D. Bunting
Cheng-Kui Qu
Michael H. Tomasson
author_sort Kevin D. Bunting
collection DOAJ
format Article
id doaj-art-8470504b18c44c2982f3aec7ccfd89b2
institution Kabale University
issn 1687-9104
1687-9112
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Advances in Hematology
spelling doaj-art-8470504b18c44c2982f3aec7ccfd89b22025-08-20T03:37:42ZengWileyAdvances in Hematology1687-91041687-91122012-01-01201210.1155/2012/606423606423Molecular-Targeted Therapies for Hematologic MalignanciesKevin D. Bunting0Cheng-Kui Qu1Michael H. Tomasson2Aflac Cancer Center of Children's Healthcare of Atlanta and Emory University Department of Pediatrics, Atlanta, GA 30322, USADepartment of Medicine, Case Western Reserve University, Cleveland, OH 44106, USADivision of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USAhttp://dx.doi.org/10.1155/2012/606423
spellingShingle Kevin D. Bunting
Cheng-Kui Qu
Michael H. Tomasson
Molecular-Targeted Therapies for Hematologic Malignancies
Advances in Hematology
title Molecular-Targeted Therapies for Hematologic Malignancies
title_full Molecular-Targeted Therapies for Hematologic Malignancies
title_fullStr Molecular-Targeted Therapies for Hematologic Malignancies
title_full_unstemmed Molecular-Targeted Therapies for Hematologic Malignancies
title_short Molecular-Targeted Therapies for Hematologic Malignancies
title_sort molecular targeted therapies for hematologic malignancies
url http://dx.doi.org/10.1155/2012/606423
work_keys_str_mv AT kevindbunting moleculartargetedtherapiesforhematologicmalignancies
AT chengkuiqu moleculartargetedtherapiesforhematologicmalignancies
AT michaelhtomasson moleculartargetedtherapiesforhematologicmalignancies